Jafron Biomedical Co.,Ltd. (SHE:300529)

ANSYS Revenue

Jafron Biomedical had revenue of 547.84M CNY in the quarter ending March 31, 2025, a decrease of -26.40%. This brings the company's revenue in the last twelve months to 2.48B, up 18.47% year-over-year. In the year 2024, Jafron Biomedical had annual revenue of 2.68B with 39.27% growth.

• Revenue (ttm): 2.48B
• Revenue Growth: +18.47%
• P/S Ratio: 7.44
• Revenue / Employee: 886.96K
• Employees: 2,797
• Market Cap: 18.47B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.68B	754.97M	39.27%
Dec 31, 2023	1.92B	-569.09M	-22.84%
Jan 1, 2023	2.49B	-184.02M	-6.88%
Jan 1, 2022	2.68B	724.67M	37.15%
Dec 31, 2020	1.95B	518.96M	36.24%